VYZULTA Rx

Select the drug indication to add to your list

VYZULTA

Glaucoma
Only 4 drugs may be compared at once

Generic Name and Formulations:

Latanoprostene bunod 0.024%; oph soln; contains benzalkonium chloride.

Select therapeutic use:

RECENT UPDATES

Monograph added.

Indications for VYZULTA:

Open-angle glaucoma. Ocular hypertension.

Adult:

>16yrs: 1 drop once daily in the PM.

Children:

≤16yrs: not recommended.

Warnings/Precautions:

Do not exceed recommended dose (may reduce efficacy). History of ocular inflammation: not recommended if active inflammation. Aphakia. Pseudophakia with torn posterior lens capsule. Risk of macular edema. Bacterial keratitis may occur (due to multiple-dose containers). Contact lenses (remove; may reinsert lenses 15mins after administration). Pregnancy. Nursing mothers.

Interactions:

Allow at least 5mins between application of other topical oph agents.

Pharmacological Class:

Prostaglandin analogue.

Adverse Reactions:

Conjunctival hyperemia, eye irritation, eye pain, instillation site pain; increased ocular pigmentation (eg, iris [may be permanent], eyelid, eyelashes), other eyelash/lid changes, macular edema (including cystoid macular edema).

Generic Availability:

NO

How Supplied:

Soln—5mL